Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent chronic liver disorders worldwide. It is closely associated with metabolic syndrome components, including type 2 diabetes, hyperlipidaemia and obesity. To date, no effective drug treatment is available for NAFLD but several clinic...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2023-04-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/silymarin-treatment-and-reduction-of-liver-enzyme-levels-in-non-alcoholic-fatty-liver-disease-a-case-report/ |